跳至主要内容
临床试验/CTRI/2021/05/033332
CTRI/2021/05/033332尚未招募2 期

Efficacy of Kanchanara and Madhunashini in Palliative treatment of the advanced oral cancer: A pilot study

Yenepoya Deemed to be University0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Oral squamous cell carcinoma (OSCC) patients with progressive disease who have completed definitive treatment
  • - OSCC patients coming with a local recurrence after a disease-free interval of more than 6 months, who are not amenable for any standard treatment
  • - Adult patients above the age of 18 years
  • - Patients with good physical performance status
  • - Patients who are able to give an informed consent

排除标准

  • - Patients who can have conventional anti-cancer therapy
  • - Patients who are not willing to participate in the trial
  • - Patients who have grade IV Trismus
  • - Patients with poor performance status
  • - Patients who are younger than 18 years
  • - Patients who are unable to give an informed consent due to poor mental status

研究者

相似试验